Methotrexate induces high level of apoptosis in canine lymphoma/leukemia cell lines.

作者: Aleksandra Pawlak , Justyna Kutkowska , Bożena Obmińska-Mrukowicz , Andrzej Rapak

DOI: 10.1016/J.RVSC.2017.09.026

关键词: OncologyLymphomaInternal medicineCancerCanine LymphomaMedicineChemotherapyAntimetaboliteMethotrexateCanine LeukemiaLeukemia

摘要: Methotrexate is an antimetabolite used in the treatment of cancer and non-malignant diseases including rheumatoid arthritis, psoriasis graft vs. host disease. Combination therapy with methotrexate was successful canine lymphoma, mammary tumor invasive urinary bladder cancer. Lymphoma, most common hematopoietic dogs, leukemia are sensitive to chemotherapy, which why may be important option for these diseases. Although already veterinary oncology its effects on cells has not been tested. The aim study evaluate first time concentration-dependent cytotoxicity capability inducing apoptosis selected lymphoma/leukemia cell lines: CLBL-1, GL-1 CL-1 as a step before vitro development new therapeutic options use methotrexate.Methotrexate exhibited inhibitory effect proliferation all examined lines different degree induction. belonged line derived from T neoplasia previously characterized by high resistance majority anticancer drugs dogs. Canine lymphoma methotrexate, this drug useful effective neoplasms especially T-type leukemia/lymphoma.

参考文章(31)
Ge-Xiu Liu, Xiao-Mao Hu, Yang-Jun Gao, Li Ding, Hong Wu, Dong-Mei He, Yuan Zhang, Combined transfection of Bcl-2 siRNA and miR-15a oligonucleotides enhanced methotrexate-induced apoptosis in Raji cells Cancer biology and medicine. ,vol. 10, pp. 16- 21 ,(2013) , 10.7497/J.ISSN.2095-3941.2013.01.003
Guido Bocci, Veronica Marchetti, Helen Owen, Mario Giorgi, Alessio Pierini, From Humans to Dogs and Back: The Translational Lesson of Metronomic Chemotherapy American Journal of Animal and Veterinary Sciences. ,vol. 7, pp. 198- 212 ,(2012) , 10.3844/AJAVSSP.2012.198.212
W.B. Morrison, Cancer Chemotherapy: An Annotated History Journal of Veterinary Internal Medicine. ,vol. 24, pp. 1249- 1262 ,(2010) , 10.1111/J.1939-1676.2010.0590.X
Andrzej Rapak, Bożena Obmińska-Mrukowicz, Aleksandra Pawlak, Iwona Zbyryt, The effect of common antineoplastic agents on induction of apoptosis in canine lymphoma and leukemia cell lines. in Vivo. ,vol. 28, pp. 843- 850 ,(2014)
Kjeld Schmiegelow, Advances in individual prediction of methotrexate toxicity: a review British Journal of Haematology. ,vol. 146, pp. 489- 503 ,(2009) , 10.1111/J.1365-2141.2009.07765.X
Barbara C. Rütgen, Sabine E. Hammer, Wilhelm Gerner, Maria Christian, Abigail Guija de Arespacochaga, Michael Willmann, Miriam Kleiter, Ilse Schwendenwein, Armin Saalmüller, Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma Leukemia Research. ,vol. 34, pp. 932- 938 ,(2010) , 10.1016/J.LEUKRES.2010.01.021
Donna M. Raditic, Joseph W. Bartges, Evidence-based Integrative Medicine in Clinical Veterinary Oncology Veterinary Clinics of North America-small Animal Practice. ,vol. 44, pp. 831- 853 ,(2014) , 10.1016/J.CVSM.2014.06.002
Yasuyuki Momoi, Yoshiko Okai, Toshihiro Watari, Ryo Goitsuka, Hajime Tsujimoto, Atsuhiko Hasegawa, Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma Veterinary Immunology and Immunopathology. ,vol. 59, pp. 11- 20 ,(1997) , 10.1016/S0165-2427(97)00053-6
Francisco J. Alvarez, William C. Kisseberth, Stacey L. Gallant, C. Guillermo Couto, Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma. Journal of Veterinary Internal Medicine. ,vol. 20, pp. 1178- 1183 ,(2006) , 10.1111/J.1939-1676.2006.TB00719.X